Feb 14, 2024 |
|
Elite Pharmaceuticals, Inc. Reports Financial Results for Third Quarter of Fiscal Year 2024 ended December 31, 2023 and Provides Conference Call Information |
Feb 8, 2024 |
|
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2024 Financial Results on February 15, 2024 |
Dec 26, 2023 |
|
Elite Pharmaceuticals Files ANDA with US FDA to Market Central Nervous System Stimulant |
Dec 12, 2023 |
|
Elite Pharmaceuticals Announces First Product Shipment of Generic Adderall XR® to Marketing Partner Prasco, LLC |
Nov 14, 2023 |
|
Elite Pharmaceuticals, Inc. Reports Financial Results for Second Quarter of Fiscal Year 2024 ended September 30, 2023 and Provides Conference Call Information |
')